AI and technologies such as computer vision are profoundly influencing the medical device and pharmaceutical industries by bolstering safety, efficiency, and accuracy. Prominent pharmaceutical companies are channeling substantial resources into AI technologies to automate procedures, augment precision, and expedite the rollout of products. Still, these enterprises must also adhere to rigorous regulatory requirements to certify the safety and effectiveness of their products, often necessitating software validation, which can be expensive and time-intensive. The escalating intricacy of AI tools may amplify these challenges, yet the enduring advantages of these technologies signal an ongoing commitment and application in these sectors.
To read more, click here.
[Source: Pharmaphorum, August 2nd, 2023]